Cite
HARVARD Citation
Oaknin, A. et al. (n.d.). 2022-RA-1297-ESGO A subgroup analysis of response rate by patient characteristics in patients with endometrial cancer receiving monotherapy dostarlimab in the GARNET trial. International journal of gynecological cancer. pp. A141-A142. [Online].